Anna-lise R. Williamson
Mount Kenya University
Thika, Kenya
Thika, Kenya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications
Short-term HPV detection dynamics across hormonal contraceptive methods in adolescent girls and young women: a secondary analysis of a randomized trial in South Africa.
Journal: Research square
Published: June 12, 2026
Impact of modification of envelope proteins on the mechanical properties of HIV virus-like particles.
Journal: Journal of the mechanical behavior of biomedical materials
Published: October 15, 2025
Genetic variability in HPV 33 and 35 E6 and E7 genes from South African and Mozambican women with different cervical cytology status.
Journal: Virology journal
Published: April 23, 2025
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.
Journal: Human vaccines & immunotherapeutics
Published: April 11, 2025
Impact of Hormonal Contraceptives on HPV Dynamics in Adolescent Girls and Young Women: Insights from a Randomized Controlled Sub-Study in South Africa.
Journal: medRxiv : the preprint server for health sciences
Published: January 27, 2025
Known Unknowns: Making Sense of Head and Neck Squamous Cell Carcinoma of Unknown Primary.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 21, 2025
Approaches to Next-Generation Capripoxvirus and Monkeypox Virus Vaccines.
Journal: Viruses
Published: December 26, 2024
Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.
Journal: Viruses
Published: December 05, 2024
Natural History of High-Risk Human Papillomavirus in Kenyan and South African Women: Implications for Vaccination Campaigns and Cervical Cancer Screening Programs.
Journal: Open forum infectious diseases
Published: August 16, 2024
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies.
Journal: Vaccines
Published: July 15, 2024
Last Updated: 09/26/2026